Because this effect was proportional to the numbers of type I NKT cells added in vitro, it would be interesting to see if greater quantities of NKT cells in vivo would shift the equilibrium in immune reaction to SAA-1 further, decreasing IL-10 mediated suppression, and restoring tumor immunity. The gene discussed is SAA1; the disease is neoplasm.